Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Chest x ray

Roche lung cancer therapy succeeds in mid-stage trial

August 17, 2015 Research and Development, Sales and Marketing Genentech, Roche, atezolizumab, lung cancer, non-small cell lung cancer

Roche’s biotech arm Genentech has scored positive results in a pivotal Phase II study of its investigational cancer immunotherapy atezolizumab. …
News
Keytruda image

Merck in immuno-oncology collaboration with major cancer research centre

August 14, 2015 Research and Development Cancer, Merck, keytruda, oncology

Merck is teaming up with the University of Texas to evaluate Merck’s anti-PD-1 therapy, Keytruda, in combination with other treatmentsA team …
News

Abbvie and Roche report success in Phase II leukaemia trial

August 13, 2015 Research and Development AbbVie, Breakthrough Therapy Designation, CLL, EMA, FDA, Roche, chronic lymphocytic leukaemia, leukaemia, venetoclax

AbbVie plans to submit regulatory applications for its leukaemia drug venetoclax to the FDA and the EMA before the end …
News
contrave

Orexigen and Takeda reboot Contrave collaboration

August 12, 2015 Research and Development Contrave, FDA, Takeda, orexigen, weight loss drugs

Orexigen has agreed to foot the $200 million bill for a new trial to prove its claims that Contrave, the …
News
Novavax

Novavax rides high on crest of RSV vaccine wave

August 12, 2015 Research and Development AbbVie, MedImmune, Novavax, RSV, vaccines

The vaccine development company Novavax has announced positive top-line data from a mid-stage clinical trial of its candidate vaccine against …
News
MedImmune building

MedImmune and Inovio collaborate on cancer vaccine

August 11, 2015 Manufacturing and Production, Research and Development AstraZeneca, HPV, Inovio, MedImmune, cancer vaccines, cervical cancer, oncology

MedImmune has entered into a license agreement and collaboration with Inovio, a biotechnology company developing DNA-based immunotherapies for cancer and …
News
aprecias_zipdose_technology_in_action

Aprecia boosts 3D printing facilities at new US site

August 11, 2015 Manufacturing and Production, Research and Development

Aprecia Pharmaceuticals, which scored a world-first by becoming the first manufacturer to gain FDA approval for a three-dimensional printed (3DP) …
News
George Freeman

UK medical innovation backed with £18m Biomedical Catalyst fund

August 10, 2015 Research and Development, Sales and Marketing

Life Sciences Minister George Freeman has announced an £18 million fund for the next generation of UK medical advances. Twelve …
News
R&D

Sanofi, Evotec and Apeiron partner on immuno-oncology

August 10, 2015 Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours

Sanofi is partnering with biotech companies Evotec and Apeiron to develop new cancer immuno-oncology therapies.The companies say the potential new …
News
MedImmune building Cambridge

MedImmune and Mirati to partner on lung cancer combo

August 6, 2015 Research and Development AstraZeneca, Cancer, MedImmune, Mirati, Mirati Therapeutics, NSCLC, durvalumab, immuno-oncology, immunotherapy, lung cancer, mocetinostat

MedImmune is entering into an exclusive clinical trial collaboration with US-based Mirati Therapeutics to test a novel immuno-oncology combination in …
News
astrazeneca image

AstraZeneca buys rights to Heptares experimental cancer treatment

August 6, 2015 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, HTL-1071, immuno-oncology

AstraZeneca has entered into a licensing agreement with Heptares for the global rights to the experimental cancer treatment HTL-1071. The …
News
Shire building

Shire goes public with rejected $30bn Baxalta bid

August 5, 2015 Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease

Shire has confirmed that it made an all-share $30 billion offer to buy Baxalta last month, citing ’a strong strategic …
News

Lilly set for Cymbalta lawsuit showdown

August 5, 2015 Research and Development cymbalta, duloxetine, lawsuit, lilly

Lilly is contesting the first in a series of lawsuits brought by patients who say the company failed to inform …
News
Spritam

First 3D-printed drug approved by FDA

August 4, 2015 Manufacturing and Production, Research and Development 3d printing, FDA, manufacturing, production

The world of medicine saw a new pharma milestone this week, with the first approval by the FDA of a …
News
Teva image

Teva buys majority stake in genomic analysis firm

August 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing CNS, Immuneering, Teva, central nervous system, genetic analysis

Teva has agreed to by a 51% equity share of genomic-analysis company Immuneering to advance treatments for diseases of the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025